Brunswick, the City’s biggest PR firm, is understood to be defending the lucrative account against other leading financial PR shops, including FD, Finsbury and Tulchan Communications.
The pitch process is expected to conclude later this month. AstraZeneca’s head of global media relations Esra Erkal-Paler confirmed that a pitch was underway and that Brunswick remained involved, but added: ‘As the process is ongoing, I’m afraid it would not be appropriate for us to comment further.’
The pitch comes at a relatively quiet time for City PR as the hoped-for flood of new London listings has barely produced a trickle.
Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.” Email: jackfriday2011(at)hotmail.co.uk
Thursday, June 02, 2011
Top city PR firms compete for pharmaceutical giant AstraZeneca business
via prweek.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment